REGN

REGN

Regeneron Pharmaceuticals Inc
Biotechnology
$748.87 -2.48% As of Apr 11, 5:08 AM
Loading chart...
Interactive chart powered by TradingView

Technical Analysis

REGN Tightening Range Signals Pending Move at $748.87

Neutral
Apr 11, 2026 at 5:08 AM • $748.87 (-2.48%)

Regeneron Pharmaceuticals Inc (REGN) fell 2.48% to finish at $748.87 on April 11.

From a technical standpoint, the outlook appears mixed:

Moving Averages The 9-day EMA ($760.69) and 21-day ($759.82) offer no clear directional bias currently.
Momentum RSI at 46.1 is in neutral territory but trending lower. MACD reads -0.13 against its -1.59 signal line (bullish).
Volatility Volatility has been compressing for 20 sessions (TTM Squeeze active), often a precursor to directional moves.

The $727.50-$779.99 range defines near-term boundaries.

TTM Squeeze Tightens Grip on REGN at $748.87

Neutral
Apr 10, 2026 at 9:01 PM • $748.87 (-2.48%)

Squeeze Play: REGN Preps for Breakout at $767.85

Neutral
Apr 9, 2026 at 9:01 PM • $767.85 (-0.99%)

Low Volatility Setup: REGN Squeezes at $775.53

Neutral
Apr 8, 2026 at 9:01 PM • $775.53 (+2.01%)

REGN Tightening Range Signals Pending Move at $760.27

Neutral
Apr 7, 2026 at 9:01 PM • $760.27 (-0.37%)
Systematic technical analysis • Updated daily after market close
Exclusive Offer

Get Trade Alerts

Receive disciplined options trade ideas with entries, targets & risk management.

Use code:
HEADSTART50
50% off your first month
Claim Offer Try Scanner

Market Summary

Current Price $748.87
Daily Change -2.48%
Sentiment Neutral
Sector Biotechnology
Last Updated Apr 11

Related Stocks

ABBV
ABBV
AbbVie Inc
AMGN
AMGN
Amgen Inc
BIIB
BIIB
Biogen Inc
MRNA
MRNA
Moderna Inc
VRTX
VRTX
Vertex Pharmaceuticals Inc
Disclaimer: This analysis is for educational purposes only. Options trading involves substantial risk. Past performance does not guarantee future results.